179 related articles for article (PubMed ID: 38212075)
1. Single-cell transcriptomic analysis of human pleura reveals stromal heterogeneity and informs
Obacz J; Valer JA; Nibhani R; Adams TS; Schupp JC; Veale N; Lewis-Wade A; Flint J; Hogan J; Aresu G; Coonar AS; Peryt A; Biffi G; Kaminski N; Francies H; Rassl DM; Garnett MJ; Rintoul RC; Marciniak SJ
Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 38212075
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype.
Røe OD; Anderssen E; Helge E; Pettersen CH; Olsen KS; Sandeck H; Haaverstad R; Lundgren S; Larsson E
PLoS One; 2009 Aug; 4(8):e6554. PubMed ID: 19662092
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor pathway inhibitor expression by human pleural mesothelial and mesothelioma cells.
Bajaj MS; Pendurthi U; Koenig K; Pueblitz S; Idell S
Eur Respir J; 2000 Jun; 15(6):1069-78. PubMed ID: 10885426
[TBL] [Abstract][Full Text] [Related]
4. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
5. Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies.
Cagle PT; Churg A
Arch Pathol Lab Med; 2005 Nov; 129(11):1421-7. PubMed ID: 16253023
[TBL] [Abstract][Full Text] [Related]
6. Normal mesothelial cell lines newly derived from human pleural biopsy explants.
Pruett N; Singh A; Shankar A; Schrump DS; Hoang CD
Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L652-L660. PubMed ID: 32726133
[TBL] [Abstract][Full Text] [Related]
7. Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets.
Ramírez-Salazar EG; Salinas-Silva LC; Vázquez-Manríquez ME; Gayosso-Gómez LV; Negrete-Garcia MC; Ramírez-Rodriguez SL; Chávez R; Zenteno E; Santillán P; Kelly-García J; Ortiz-Quintero B
Exp Mol Pathol; 2014 Dec; 97(3):375-85. PubMed ID: 25236577
[TBL] [Abstract][Full Text] [Related]
8. Pleural biopsy in the diagnosis of malignant mesothelioma.
Herbert A; Gallagher PJ
Thorax; 1982 Nov; 37(11):816-21. PubMed ID: 7163999
[TBL] [Abstract][Full Text] [Related]
9. [Localized benign pleural mesothelioma].
Vorpahl U; Buhr J; Bohle RM; Berghäuser KH; Henneking K
Langenbecks Arch Chir; 1994; 379(5):307-9. PubMed ID: 7990627
[TBL] [Abstract][Full Text] [Related]
10. Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma.
Cioce M; Ganci F; Canu V; Sacconi A; Mori F; Canino C; Korita E; Casini B; Alessandrini G; Cambria A; Carosi MA; Blandino R; Panebianco V; Facciolo F; Visca P; Volinia S; Muti P; Strano S; Croce CM; Pass HI; Blandino G
Oncogene; 2014 Nov; 33(46):5319-31. PubMed ID: 24240684
[TBL] [Abstract][Full Text] [Related]
11. Extended pleurectomy decortication for the treatment of malignant pleural mesothelioma.
Maat A; Durko A; Thuijs D; Bogers A; Mahtab E
Multimed Man Cardiothorac Surg; 2019 Nov; 2019():. PubMed ID: 31751008
[TBL] [Abstract][Full Text] [Related]
12. Differential Susceptibility of Human Pleural and Peritoneal Mesothelial Cells to Asbestos Exposure.
Dragon J; Thompson J; MacPherson M; Shukla A
J Cell Biochem; 2015 Aug; 116(8):1540-52. PubMed ID: 25757056
[TBL] [Abstract][Full Text] [Related]
13. Imaging of Malignant Pleural, Pericardial, and Peritoneal Mesothelioma.
Strange CD; Marom EM; Ahuja J; Shroff GS; Gladish GW; Carter BW; Truong MT
Adv Anat Pathol; 2023 Jul; 30(4):280-291. PubMed ID: 36395181
[TBL] [Abstract][Full Text] [Related]
14. Pleural mesothelioma classification-update and challenges.
Dacic S
Mod Pathol; 2022 Jan; 35(Suppl 1):51-56. PubMed ID: 34465883
[TBL] [Abstract][Full Text] [Related]
15. Microdissection, mRNA amplification and microarray: a study of pleural mesothelial and malignant mesothelioma cells.
Mohr S; Bottin MC; Lannes B; Neuville A; Bellocq JP; Keith G; Rihn BH
Biochimie; 2004 Jan; 86(1):13-9. PubMed ID: 14987796
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.
Laszlo V; Hoda MA; Garay T; Pirker C; Ghanim B; Klikovits T; Dong YW; Rozsas A; Kenessey I; Szirtes I; Grusch M; Jakopovic M; Samarzija M; Brcic L; Kern I; Rozman A; Popper H; Zöchbauer-Müller S; Heller G; Altenberger C; Ziegler B; Klepetko W; Berger W; Dome B; Hegedus B
J Pathol; 2015 Oct; 237(2):203-14. PubMed ID: 26011651
[TBL] [Abstract][Full Text] [Related]
17. [Pleural mesothelioma. Cytology and molecular diagnostics].
Vlajnic T; Savic S; Bubendorf L
Pathologe; 2014 Nov; 35(6):591-6. PubMed ID: 25069847
[TBL] [Abstract][Full Text] [Related]
18. β-catenin expression in benign and malignant pleural disorders.
Anani W; Bruggeman R; Zander DS
Int J Clin Exp Pathol; 2011; 4(8):742-7. PubMed ID: 22135721
[TBL] [Abstract][Full Text] [Related]
19. The separation of benign and malignant mesothelial proliferations.
Churg A; Colby TV; Cagle P; Corson J; Gibbs AR; Gilks B; Grimes M; Hammar S; Roggli V; Travis WD
Am J Surg Pathol; 2000 Sep; 24(9):1183-200. PubMed ID: 10976692
[TBL] [Abstract][Full Text] [Related]
20. Nucleolin and nucleophosmin expression patterns in pulmonary adenocarcinoma invading the pleura and in pleural malignant mesothelioma.
Masiuk M; Waloszczyk P; Lewandowska M; Dobak E; Urasinska E
Thorac Cancer; 2020 Sep; 11(9):2529-2535. PubMed ID: 32671956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
